About N-(1,3-benzodioxol-5-ylmethyl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide
N-(1,3-benzodioxol-5-ylmethyl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide (PubChem CID 1452351) has the molecular formula C14H17N5O3S
and a molecular weight of 335.39 g/mol. Its IUPAC name is N-(1,3-benzodioxol-5-ylmethyl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide.
Analyze N-(1,3-benzodioxol-5-ylmethyl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-(1,3-benzodioxol-5-ylmethyl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide?
The IUPAC name of N-(1,3-benzodioxol-5-ylmethyl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide (CID 1452351) is N-(1,3-benzodioxol-5-ylmethyl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide.
What is the SMILES notation for N-(1,3-benzodioxol-5-ylmethyl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide?
The canonical SMILES for N-(1,3-benzodioxol-5-ylmethyl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide is CC(C)n1nnnc1SCC(=O)NCc1ccc2c(c1)OCO2.
What is the InChIKey of N-(1,3-benzodioxol-5-ylmethyl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide?
The InChIKey is MJCKXPZVUYQFHZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H17N5O3S/c1-9(2)19-14(16-17-18-19)23-7-13(20)15-6-10-3-4-11-12(5-10)22-8-21-11/h3-5,9H,6-8H2,1-2H3,(H,15,20).
What are the key properties of N-(1,3-benzodioxol-5-ylmethyl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide?
N-(1,3-benzodioxol-5-ylmethyl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide has a molecular weight of 335.39 g/mol, XLogP of 1.39, 6 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1,3-benzodioxol-5-ylmethyl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide is sourced from PubChem (CID 1452351), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).